Companies › Intuitive Surgical · Global Markets & Policy
Intuitive Surgical, Inc.
- Nasdaq: ISRG
US maker of the da Vinci robotic surgery systems and the instruments used with them.
Next earnings report: Oct 20, 2026. Intuitive Surgical quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $5.0M, purchases $0. All Intuitive Surgical insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Fredrik Widman VP Corporate Controller | Open-market sale 10b5-1 plan | 546 | $374.44 | $204K | Form 4 ↗ |
| Sep 15, 2026 | Fredrik Widman VP Corporate Controller | Open-market sale 10b5-1 plan | 543 | $374.44 | $203K | Form 4 ↗ |
| Sep 11, 2026 | Mark Brosius EVP & Chief Mfg and Supply Cha | Open-market sale 10b5-1 plan | 25 | $365.79 | $9K | Form 4 ↗ |
| Sep 10, 2026 | Mark Brosius EVP & Chief Mfg and Supply Cha | Open-market sale 10b5-1 plan | 23 | $347.66 | $8K | Form 4 ↗ |
| Sep 9, 2026 | Mark Brosius EVP & Chief Mfg and Supply Cha | Open-market sale 10b5-1 plan | 23 | $350.20 | $8K | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $6.2B | $7.1B | $8.4B | $10.1B |
| Operating income | $1.6B | $1.8B | $2.3B | $2.9B |
| Net income | $1.3B | $1.8B | $2.3B | $2.9B |
| Diluted EPS | $3.65 | $5.03 | $6.42 | $7.87 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-07-27 · 8-K — Bylaws or charter amendment
- 2026-07-21 · 10-Q
- 2026-07-16 · 8-K — Results of operations
- 2026-05-28 · 8-K — Director or officer change
- 2026-05-04 · 8-K — Director or officer change; Shareholder vote results; Regulation FD disclosure
- 2026-04-22 · 10-Q
- 2026-04-21 · 8-K — Results of operations
- 2026-03-13 · DEF 14A
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.